Navigation Links
Celsion Receives Fast Track Designation for ThermoDox® Development Program to Treat Primary Liver Cancer
Date:8/24/2010

COLUMBIA, Md., Aug. 24 /PRNewswire-FirstCall/ -- Celsion Corporation (Nasdaq: CLSN), a leading oncology drug development company, today announced that the U.S. Food and Drug Administration (FDA) has designated the HEAT Study of its investigational drug, ThermoDox®, in combination with radiofrequency ablation (RFA), as a Fast Track Development Program.  ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, is currently being evaluated under a Special Protocol Assessment (SPA) agreement with the FDA in a 600 patient global Phase III trial in patients with non-resectable hepatocellular carcinoma (HCC), commonly referred to as primary liver cancer.  With nearly 70% of patients enrolled in the trial, Celsion is targeting to complete patient enrollment by year end 2010.

"We are very pleased to receive the Agency's Fast Track Designation for ThermoDox," stated Mr. Michael H. Tardugno, Celsion's President and Chief Executive Officer.  "Fast Track Designation is an acknowledgement that HCC is a significant unmet medical need representing a life threatening disorder.  It also recognizes the challenges facing pharmaceutical companies to develop effective new treatments for this difficult disease.  Together with the FDA's SPA agreement, granting accelerated review for the HEAT Study, the Fast Track status provides Celsion with the shortest time to approval.  Supported further by the National Cancer Institute's recent designation of the HEAT Study as a Priority Clinical Trial, it is clear that the major U.S. healthcare agencies and the liver cancer medical community recognize the potential of ThermoDox. We look forward to working with the FDA and other regulatory agencies around the world to make ThermoDox available to patients as soon as possible."

The FDA's Fast Track Development Program provides for expedited regulato
'/>"/>

SOURCE Celsion Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Celsion Announces CFO Departure
2. Quest Diagnostics Care360™ EHR Module Receives Preliminary ARRA IFR Stage 1 Certification
3. Hospira Japan Receives Approval for New Indication for Precedex IV™ 200ug
4. EntreMed Receives NASDAQ Listing Rule 5550(b)(2) Determination Letter
5. Renhuang Receives Patent for Product Package Design for Compound Honeysuckle Granules
6. KemPharm, Inc. Receives Notice of Issuance From USPTO on Patent Protecting Companys ADHD Prodrug Technology
7. PDL BioPharma Receives Letter from Genentech Relating to European Patents
8. Sigma-Aldrich® Receives National Institutes of Health Funding for Cardiovascular Disease Research
9. PolyGel® Receives SADMERC Approval for L-Code L3670 for ThermoActive™ Cold & Hot Mobile Compression Shoulder Orthosis
10. Accurays CyberKnife® G4 System Receives Shonin Approval
11. AdvanDx Receives FDA 510(k) Clearance for 90 Minutes Protocol for Yeast Traffic Light® PNA FISH®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 Nonin Medical, Inc., ... in noninvasive medical monitoring, today announced that the Food ... 3231 OEM/eHealth finger pulse oximeter for use in ... oximeter plugs into a telemedicine hub or kiosk through ... rate in pediatric to adult patients. The Model 3231 ...
(Date:8/28/2014)... , Aug. 28, 2014  In recognition of the ... complications from the flu, pneumonia, shingles and other ... have declared September to be Senior Vaccination Month. ... it is important that adults ages 65 years ... vaccinations. CVS pharmacists and MinuteClinic nurse practitioners and ...
(Date:8/28/2014)... , Aug. 28, 2014  Robotic surgery is ... media, both for the promise of improved outcomes ... quick deployment of surgical robots and market pressures ... facilities to evaluate their robotic surgery training programs ... team.    ECRI Institute ( www.ecri.org ...
Breaking Medicine Technology:Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 2Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 3Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 4Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 5
... Jan. 25 Richard Cooper Woodyard , Vice ... January 19th after a 2-year fight with cancer. ... eCardio as Vice President, Business Development. As Vice President, Sales, ... responsible for identifying, negotiating and integrating new partners, products, technologies, ...
... , SOUTH SAN FRANCISCO, Calif. , ... announced today that Institutional Shareholder Services/Risk Metrics Group (ISS) and ... advisory firms, recommend that VaxGen stockholders vote "FOR" the proposed ... Proposal to adjourn the VaxGen special meeting, if necessary, to ...
Cached Medicine Technology:Richard Woodyard, Vice President of Sales at eCardio, Loses Fight Against Cancer 2ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE 2ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE 3ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE 4ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE 5
(Date:8/29/2014)... 29, 2014 Hope For The Warriors® ... Spouse/Caregiver Scholarships. Scholarships are awarded two times each year ... to spouses of fallen service members. Hope For The ... sense of self, restoring the family unit, and restoring ... , The Spouse/Caregiver Scholarship Program identifies, recognizes, and ...
(Date:8/29/2014)... Boca Raton, Florida (PRWEB) August 29, 2014 ... in which surgeons, like Dr. Scott Katzman of ... endoscopic instruments to view and perform repairs. Problems ... around the vertebrae cause a number of treatment needs ... This type spine surgery involves an advantageously small incision ...
(Date:8/29/2014)... Stamford, CT (PRWEB) August 29, 2014 ... that firm founder Russell J. Berkowitz was included in ... of Best Lawyers® in America. Best Lawyers® is the ... U.S. and beyond. , An inclusion in Best ... community as it only lists attorneys who have earned ...
(Date:8/29/2014)... Asheville, NC (PRWEB) August 29, 2014 ... District in the North Carolina General Assembly, spent the ... Aeroflow Healthcare and touring our facilities. , Representative Moffitt’s ... Asheville based durable medical equipment (DME) company and to ... could impact DME providers such as Aeroflow. , ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 http://www.fdanews.com/CTMPR ... of Clinical Trials Magnifier Weekly. , Clinical Trial Magnifier ... world every week and reports all the fresh changes. ... is able to extract just the information readers need. ... drill down using links in the newsletter to focus ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors Announces Fall 2014 Spouse/Caregiver Scholarship Recipients 2Health News:Hope For The Warriors Announces Fall 2014 Spouse/Caregiver Scholarship Recipients 3Health News:Advancements in Spine Surgery Offered by this Modern Florida Surgery Group are Cutting Out Historically Demanding Recovery Times 2Health News:Russell J. Berkowitz, Esq. of The Berkowitz Law Firm LLC Selected by Best Lawyers® for Personal Injury Litigation 2Health News:North Carolina Representative Tim Moffitt Visits Aeroflow Healthcare 2Health News:FDAnews Accounces New Newsletter: Clinical Trial Magnifier Weekly Provides the Most Up-to-Date Clinical Trial Data 2Health News:FDAnews Accounces New Newsletter: Clinical Trial Magnifier Weekly Provides the Most Up-to-Date Clinical Trial Data 3Health News:FDAnews Accounces New Newsletter: Clinical Trial Magnifier Weekly Provides the Most Up-to-Date Clinical Trial Data 4
... for May 12, 2008 at 1:30 p.m. (Pacific); ... webcast at http://www.adventrx.com , SAN DIEGO, May 5 ... it will host a conference call with,simultaneous webcast to discuss ... p.m. Pacific / 4:30 p.m. Eastern. Evan M. Levine, Chief,Executive ...
... Veterinary Medical,Association (AVMA) reiterated today, at the start ... veterinarians working in the,public sector and urged Congress ... Veterinarians fill essential positions at agencies, including ... of Agriculture,the US Food and Drug Administration and ...
... Mich.---A new study suggests that extra iron for infants who ... the debate over optimal iron supplement levels and could have ... "Our results for 25 years of research show problems with ... a big deal, it,s really unexpected," said Dr. Betsy Lozoff, ...
... LATEST REVIEW SUGGESTS LABAs ARE SAFE AND EFFECTIVE FOR ... of long-acting β2-agonists (LABA) to increased risk for adverse ... to severe chronic obstructive pulmonary disease (COPD); however, a ... In a new metaanalysis, researchers from Spain, Argentina, and ...
... York, NY A preliminary analysis of ongoing research suggests that ... BRCA1/2 mutation may face a greater chance for developing a ... risk of cancer in these women, should sentinel node biopsy ... can women best be counseled after these findings? , ...
... help bridge this knowledge gap, experts say , , SUNDAY, ... babies have a surprisingly low knowledge of child development, ... or how they should act, a new study finds. ... don,t know that 1-year-olds can,t tell the difference between ...
Cached Medicine News:Health News:AVMA Recognizes Public Veterinarians Urges Congressional Action 2Health News:Iron supplements might harm infants who have enough 2Health News:News briefs: May issue of the journal Chest 2Health News:Second breast cancer may be greater than thought for high-risk women without BRCA mutations 2Health News:One-Third of Parents Lack Facts About Child Development 2Health News:One-Third of Parents Lack Facts About Child Development 3
... nebulizers offer a spill-proof design and effective ... 45° angle. All medical nebulizers are free-standing ... of configurations are available., ,All Portex® ... ,Portex® medication nebulizers feature consistently fine misting ...
... medication as well as humidification, try Flo-Mist™., ... high volume, continuous medication nebulizer (CMN), engineered ... Its 200 ml reservoir and jet flow ... of nebulized medication delivery at 25 ml/hr. ...
Infant Nebulizer Kit W/Misty-Nebulizer 30/CS CE Mark Only...
... and Respiratory Products, ,Westmed designs, manufacturers ... Anesthesia and Respiratory professionals. Our mission is ... the clinician's ability to deliver quality medical ... bottom line. , ,Our web site ...
Medicine Products: